Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guro E Lind

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Best Practice & Research. Clinical Gastroenterology|November 29, 2011
Primary sclerosing cholangitis and malignancyKirsten Muri Boberg, Guro E Lind
Epigenomics|June 16, 2017
Details matter: the role of genomic location and assay standardization in DNA methylation analysesGuro E Lind, Manon van Engeland
Seminars in Cancer Biology|December 19, 2017
Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectivesHege Marie Vedeld, Ajay Goel, Guro E Lind
Gastroenterology|April 6, 2007
DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumorsGuro E Lind, Terje Ahlquist, Ragnhild A Lothe
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 30, 2012
Vimentin in upper gastrointestinal pathologies--letterGuro E Lind, Deeqa Ahmed, Ragnhild A Lothe
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 29, 2007
The epigenome of testicular germ cell tumorsGuro E Lind, Rolf I Skotheim, Ragnhild A Lothe
Endocrine-Related Cancer|August 27, 2011
Quantitative validation of GJC1 promoter hypermethylation in benign and malignant colorectal tumorsDeeqa Ahmed, Ragnhild A Lothe, Edgar Rivedal, et al.
European Urology|September 25, 2025
Re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30Heidi Pharo, Hege Marie Vedeld, Rolf Wahlqvist, et al.
Molecular Oncology|August 5, 2025
PoDCall: a robust tool for automated droplet classification in DNA-methylation droplet digital PCRHans Petter Brodal, Heidi Pharo, Hege Marie Vedeld, et al.
Clinical Epigenetics|June 2, 2018
Re-assessing <i>ZNF331</i> as a DNA methylation biomarker for colorectal cancerHege Marie Vedeld, Arild Nesbakken, Ragnhild A Lothe, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Best Practice & Research. Clinical Gastroenterology|November 29, 2011
Primary sclerosing cholangitis and malignancyKirsten Muri Boberg, Guro E Lind
Epigenomics|June 16, 2017
Details matter: the role of genomic location and assay standardization in DNA methylation analysesGuro E Lind, Manon van Engeland
Seminars in Cancer Biology|December 19, 2017
Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectivesHege Marie Vedeld, Ajay Goel, Guro E Lind
Gastroenterology|April 6, 2007
DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumorsGuro E Lind, Terje Ahlquist, Ragnhild A Lothe
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 30, 2012
Vimentin in upper gastrointestinal pathologies--letterGuro E Lind, Deeqa Ahmed, Ragnhild A Lothe
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 29, 2007
The epigenome of testicular germ cell tumorsGuro E Lind, Rolf I Skotheim, Ragnhild A Lothe
Endocrine-Related Cancer|August 27, 2011
Quantitative validation of GJC1 promoter hypermethylation in benign and malignant colorectal tumorsDeeqa Ahmed, Ragnhild A Lothe, Edgar Rivedal, et al.
European Urology|September 25, 2025
Re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30Heidi Pharo, Hege Marie Vedeld, Rolf Wahlqvist, et al.
Molecular Oncology|August 5, 2025
PoDCall: a robust tool for automated droplet classification in DNA-methylation droplet digital PCRHans Petter Brodal, Heidi Pharo, Hege Marie Vedeld, et al.
Clinical Epigenetics|June 2, 2018
Re-assessing <i>ZNF331</i> as a DNA methylation biomarker for colorectal cancerHege Marie Vedeld, Arild Nesbakken, Ragnhild A Lothe, et al.
Pageof 8